Business View Oceania

12 BUSINESS VIEW OCEANIA VOLUME 4, ISSUE 12 Early diagnosis of osteoporosis is crucial to reducing fracture rates, and their subsequent impacts and costs CURVEBEAM AI and their doctors of their fracture risk, therefore helping target treatment to prevent fragility fractures.” “Early diagnosis of osteoporosis is crucial to reducing fracture rates, and their subsequent impacts and costs,” adds CEO of Healthy Bones Australia, Greg Lyubomirsky. “We need to focus on prevention, which means understanding risk factors for poor bone health, early diagnosis, and appropriate and prompt treatment. This new diagnostic tool, used with BMD testing, can assist Healthy Bones Australia’s ongoing work in generating awareness of the importance of bone health, to ensure all Australians are better protected against sustaining fractures in the future.” University of Melbourne Professor and Medical Director of CurveBeam AI, Ego Seeman, also weighs in. “This new diagnostic tool provides a new direction for identifying women at risk of breaking a bone in the next year or two, by measuring their bone structure. This early detection will help doctors to treat before a fracture occurs.” About Healthy Bones Australia Healthy Bones Australia, formerly Osteoporosis Australia, is a national, not-for-profit organisation, and the leading consumer body working to reduce unwanted broken bones and improve bone health across Australia. Healthy Bones Australia was established in 2001 in response to the then growing number of Australians with poor bone health, and lack of health focus on preventing osteoporosis. Healthy Bones Australia strives to increase community and health professional awareness of osteoporosis and advocating to government, to reduce the impact of the disease nation-wide. To learn more about Healthy Bones Australia, head to healthybonesaustralia.org.au . • Support new and innovative osteoporosis diagnostic opportunities He continues, “I am delighted to announce that we are on our way to fulfilling one of our goals by partnering with the Australian company, CurveBeam AI, in the validation of a new diagnostic tool for osteoporosis. Following a decade of research, the new tool OssView™ is a compact, high-resolution CT scanner combined with a new bone fragility software that generates a Structural Fragility Score. An OssView™ result, used with Bone Mineral Density testing, is expected to greatly assist GPs and Specialists with identifying patients who are at high-risk of fracture. The OssView™ test will also help to improve access for elderly people in remote, rural, or nursing home settings, to better inform them